The fetal form of the acetylcholine receptor distinguishes rhabdomyosarcomas from other childhood tumors

American Journal of Pathology

Volumn 152, Issue 2, 1998, Pages 437-444

  Gattenloehner, Stefan ^a   Vincent, Angela ^d   Leuschner, Ivo ^b   Tzartos, Socrates ^e   Müller Hermelink, Hans Konrad ^a   Kirchner, Thomas ^c   Marx, Alexander ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHOLINERGIC RECEPTOR; DNA; MEMBRANE PROTEIN; MESSENGER RNA; NICOTINIC RECEPTOR; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; FETUS; GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; METASTASIS; MINIMAL RESIDUAL DISEASE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SOUTHERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FETUS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, CHOLINERGIC; RHABDOMYOSARCOMA; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0031883454     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Triche TJ: Pathology of pediatric malignancies. Principles and Practice of Pediatric Oncology. Edited by Pizzo PA, Poplack PG. Philadelphia; JB Lippincott, 1993, pp 115-152
2. Diller L: Rhabdomyosarcoma and other soft tissue sarcomas of childhood. Curr Opin Oncol 1992, 4:689-695
3. Newton WA Jr, Gehan EA, Webber BL, Marsden HB, van Unnik AJM, Hamoudi AB, Tsokos M, Shimada H, Harms D, Schmidt D, Ninfo V, Cavanazza A, Gonzalez-Crussi F, Parham DM, Reiman HM, Asmar L, Beltangady MS, Sachs N, Triche TJ, Maurer HM: Classification of rhabdomyosarcomas and related sarcomas: pathologic aspects and proposal for a new classification: an intergroup rhabdomyosarcoma study. Cancer 1995, 76:1073-1085
4. Carter RL, McCarthy KP, Macin LG, Jameson CF, Philp ER, Pinkerton CR: Expression of desmin and myoglobin in rhabdomyosarcomas and in developing skeletal muscle. Histopathology 1989, 15:585-595
5. Dias P, Parham DM, Shapiro DN, Webber BL, Houghton PJ: Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Am J Pathol 1990, 137:1283-1291
6. deJong ASH, Albus-Lutter CE, van Raamsdonk W, Voute PA: Myosin and myoglobin as tumor markers in the diagnosis of rhabdomyosarcoma. Am J Surg Pathol 1984, 521-528
7. Miettinen M: Antibody specific to muscle actins in the diagnosis and classification of soft tissue tumors. Am J Pathol 1988, 130:205-215
8. Osborn M, Hill C, Altmannsberger M, Weber K: Monoclonal antibodies to titin in conjunction with antibodies to desmin separate rhabdomyosarcomas from other tumor types. Lab Invest 1986, 55:101-108
9. Parham DM, Webber B, Holt H, Williams WK, Maurer H: Immunohistochemical study of childhood rhabdomyosarcoma and related neoplasms: result of an intergroup rhabdomyosarcoma study project. Cancer 1991, 67:3072-3080
10. Pinto A, Paslawski D, Sarnat HB, Parham DM: Immunohistochemical evaluation of dystrophin in small round cell tumors of childhood. Mod Pathol 1993, 6:679-683
11. Rosai J, Dias P, Parham DM, Shapiro DN, Houghton P: MyoD1 protein expression in alveolar soft part sarcoma as confirmatory evidence of its skeletal muscle nature. Am J Surg Pathol 1991, 15:974-981
12. Sainati L, Stella M, Montaldi A, Bolcato S, Guercini N, Bonan F, Ninfo V, Zanesco L, Basso G: Value of cytogenetics in the differential diagnosis of the small round cell tumors of childhood. Med Pediatr Oncol 1992, 20:130-135
13. Biegel JA, Meek RS, Parmiter AH, Conrad K, Emanuel BS: Chromosomal translocation t(1;13) (p36;q14) in a case of rhabdomyosarcoma. Genes Chromosomes & Cancer 1991, 3:483-484
14. Douglass EC, Valentine M, Etcubanas E, Parham D, Webber BL, Houghton PJ, Houghton JA, Green AA: A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet 1987, 45: 148-155
15. Douglass EC, Shapiro DN, Valentine M, Rowe ST, Caroll AJ, Raney RB, Ragab AH, Abella SM, Parham DM: Alveolar rhabdomyosarcoma with t(2;13): cytogenetic findings and clinicopathological correlations. Med Pediatr Oncol 1993, 21:83-87
16. Douglass-EC, Rowe ST, Valentine M, Parham DM, Berkow R, Bowman WP, Maurer HM: Variant translocations of chromosome 13 in alveolar rhabdomyosarcomas. Genes Chromosomes & Cancer 1991, 3:480-482
17. Trent J, Casper J, Meltzer P, Thompson F, Fogh J: Nonrandom chromosome alterations in rhabdomyosarcoma. Cancer Genet Cytogenet 1985, 16:189-197
18. Turc-Carel C, Lizard-Nacol S, Justrabo E, Fvrot M, Philip T, Tabone E: Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet 1986, 19:361-362
19. Galili N, Davis RJ, Fredericks WJ, Mukhopadhyay S, Rauscher FJ, Emanuel BS, Rovera G, Barr FG: Fusion of a forkhead domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nature Genet 1993, 5:230-235
20. Wang NP, Marx J, McNutt MA, Rutledge JC, Gown AM: Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. Am J Pathol 1995, 147:1799-1810
21. Engel AG, Franzini-Armstrong C (Eds): Myology: Basic and Clinical. New York, McGraw-HNI 1994, pp 1135-1137
22. Chamberlain JS, Corrado K, Rafael JA, Cox GA, Hauser M, Lumeng C: Interactions between dystrophin and the sarcolemma membrane. Soc Gen Physiol Ser 1997, 52:19-29
23. Chelly J, Kaplan JC, Maire P, Gautron S, Kahn A: Transcription of dystrophin gene in human and non-muscle tissues. Nature 1988, 333:858-860
24. Wessels A, Ginjaar IB, Moorman AF, Van-Ommen GB: Different localization of dystrophin in developing and adult human skeletal muscle. Muscle Nerve 1991, 14:1-7
25. Tinsley JM, Blake DJ, Roche A, Fairbrother U, Riss J, Byth BC, Knight AE, Kendrick-Jones J, Suthers GK, Love DR, Edwards YH, Davies KE: Primary structure of dystrophin-related protein. Nature 1992, 360: 591-593
26. Pappo AS, Shapiro DN, Crist WM: Rhabdomyosarcoma: biology and treatment. Pediatr Clin North Am 1997, 44:953-972
27. Changeux JP: Functional organization of the nicotinic acetylcholine receptor. CR Acad Sci III 1992, 314(9 suppl):89-94
28. Tzartos SJ: Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor. In Vivo 1988, 2:105-110
29. Whiting PJ, Vincent A, Schluep M, Newsom-Davis J: Monoclonal antibodies that distinguish between normal and denervated human acetylcholine receptor. J Neuroimmunol 1986, 11:223-235
30. Heidenreich F, Vincent A, Roberts A, Newsom-Davis J: Epitopes on human acetylcholine receptor defined by monoclonal antibodies and myasthenia gravis sera. Autoimmunity 1988, 1:285-297
31. Missias AC, Chu GC, Klocke BJ, Sanes JR, Merlite JP: Maturation of acetylcholine receptor in skeletal muscle: regulation of the AChR-gamma-to-epsilon-switch. Dev Biol 1996, 179:223-238
32. Witzemann V, Barg B, Nishikawa Y, Sakman B, Numa S: Differential regulation of muscle acetylcholine receptor γ- and ε-subunit mRNAs. FEBS Lett 1987, 223:104-112
33. Hara H, Hayashi K, Ohta K, Itoh N, Ohta M: Nicotinic acetylcholine receptor mRNAs in myasthenic thymuses: association with intrathymic pathogenesis of myasthenia gravis. Biochem Biophys Res Commun 1993, 194:1269-1275
34. Hesselmans LFGM, Jennekens FGI, van den Oord CJM, Veldman H, Vincent A: Development of innervation of skeletal muscle fibers in man: relation to acetylcholine receptors. Anat Rec 1993, 236:553-562
35. Kirchner T, Geuder KI, Marx A, Müller-Hermelink HK: Detection of nicotinic acetylchline receptors in tumors with rhabdomyomatous differentiation. Verh Dtsch Ges Pathol 1990, 74:409-414
36. Kaminski HJ, Kusner LL, Block CH: Expression of acetylcholine receptor isoforms at extraocular muscle endplates. Invest Ophthalmol Vis Sci 1996, 37:345-351
37. Stratton MR, Reeves BR, Cooper CS: Misidentified cell. Nature 1989, 337:311-312
38. Sophianos D, Tzartos S: Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenia gravis sera. J Autoimmun 1989, 2:777-789
39. Marx A, Kirchner T, Hoppe F, O'Connor R, Schalke B, Tzartos S, Müller-Hermelink HK: Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis. Am J Pathol 1989, 134:865-877
40. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
41. Beeson D, Brydson M, Newsom-Davis J: Nucleotide sequence of human muscle actelycholine receptor beta-subunit. Nucleic Acids Res 1989, 17:4391
42. Beeson D, Brydson M, Betty M, Jeremiah S, Povey S, Vincent A, Newsom-Davis J: Primary structure of the human muscle acetylcholine receptor-cDNA: cloning of the gamma- and epsilon-subunit. Eur J Biochem 1993, 215:229-238
43. Luther MA, Schopfer R, Whiting P, Casey B, Blatt Y, Montai MS, Montai M, Lindstrom J: A muscle acetylcholine receptor is expressed in human cerebellar medulloblastoma cell line TE 671. J Neurosci 1989, 9:1082-1096
44. Schoepfer R, Luther M, Lindstrom J: The human medulloblastoma cell line TE 671 expresses a muscle-like acetylcholine-receptor: cloning of the alpha-subunit. FEBS Lett 1988, 226:235-240
45. Arcari P, Martinell R, Salvatore F: The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res 1984, 12:1979-1989
46. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning 2. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
47. Triche TJ: Molecular genetic and cytogenetic analysis of childhood solid tumors. Molecular Pathology, Special Course 1992: New Insights Into Cancer Provided by Advances in Molecular and Cell Biology. Atlanta, GA, March 19, 1992
48. Davis RL, Weintraub H, Lassar AB: Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51:987-1000
49. Pinney DF, Pearson-White SH, Konieczny SF, Latham KE, Emerson CP: Myogenic lineage determination and differentiation: evidence for a regulatory gene pathway. Cell 1988, 53:781-793
50. Scrable H, Witte D, Shimada H, Seemayer T, Sheng WW, Soukoup S, Koufos A, Houghton P, Lampkin B, Cavenee W: Molecular differential pathology of rhabdomyosarcoma. Genes Chromosomes & Cancer 1989, 1:23-35
51. Tonin PN, Scrable H, Shimada H, Cavenee WK: Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development. Cancer Res 1991, 51:5100-5106
52. Wakkach A, Guyon T, Bruand C, Tzartos S, Cohen-Kaminsky S, Berrih-Aknin S: Expression of acetylcholine receptor genes in human thymic epithelial cells. J Immunol 1996, 157:3752-3760
53. Wright WE, Sasson DA, Lin VK: Myogenin, a factor regulating myogenesis, has a domain homologous to myoD. Cell 1989, 56:607-617
54. d'Amore ES, Tollot M, Stracca-Pansa V, Menegon A, Meli S, Carli M, Ninfo V: Therapy associated differentiation in rhabdomyosarcomas. Mod Pathol 1994, 7:69-75
55. Vincent A, Newland C, Brueton L, Beeson D, Riemersma S, Huson SM, Newsom-Davis J: Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet 1995, 346: 24-25
56. Kuncl RW, Drachman DB, Adams R, Lehar M: 3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptor. J Pharmacol Exp Ther 1993, 267: 582-589